HOME >> MEDICINE >> NEWS
Expert calls for common sense, science in national response to medicinal herbs

CHAPEL HILL -- Because plants have been used to treat illness since before modern humans evolved and will remain popular into the foreseeable future, the nation needs to combine common sense with good science in its response to medicinal herbs.

That's the view of Dr. Varro E. Tyler, one of the world's leading experts on the subject.

"In my opinion, this is a scandalous situation," Tyler said. "Here we have products that are used by one-third of the adult population in the United States with a retail annual market value approximating $4 billion, and the FDA, by establishing artificially high proof-of-efficacy hurdles, refuses them drug approval. Compare this with the situation that has worked so well in Germany for many years in which 'reasonable' amounts of proof are accepted as evidence of efficacy for phytomedicines, allowing the products to become an integral part of mainstream medicine."

Author of more than 30 books, Tyler is distinguished professor emeritus of pharmacognosy at Purdue University and dean of pharmacy emeritus. He spoke Thursday (March 2) at the University of North Carolina at Chapel Hill at the first international scientific conference on medicinal herbs.

"The ancient origins of herbal medicine are indisputable," he said.

Archaeologists have found pollen and flower fragments from different medicinal plants in Neanderthal tombs in Iraq dating back some 60,000 years, the scholar said. Cannabis -- the marijuana plant -- is believed to have been used for more than 8,000 years in China, and opium, first produced in Mesopotamia, has been an important painkiller for some 5,400.

"The mummified human discovered in the Italian Alps in 1991 and now referred to as 'the iceman' possessed two pieces of birch fungus," Tyler said. "Scientists speculate that this 5,300-year-old human was using the fungus as a drug, possibly as a treatment for intestinal parasites."

The golden age of herbal medicine in the United States straddled th
'"/>

Contact: David Williamson
david_williamson@unc.edu
919-962-8596
University of North Carolina at Chapel Hill
1-Mar-2000


Page: 1 2 3 4

Related medicine news :

1. Expert panel calls for raising the bar in treating schizophrenia
2. Experts debate benefits, dangers of chlorine in C&EN point-counterpoint
3. Expert nurse paves the way with in-demand treatment option; Century-old brachytherapy rejuvenated
4. Expert calls for standard epinephrine doses when treating children in cardiac arrest
5. Experts to discuss new advances in IBS therapy and its affect on IBS sufferers
6. Experts to discuss emerging technologies in GI diagnosis and treatment
7. Experts to discuss the affects of non-steroidal anti-inflammatory drugs (NSAIDs)
8. Experts present new research on the hot topics of aging at GSAs Annual Meeting
9. Expert reviews cannot be trusted
10. Experts welcome major reforms to the coroners service
11. Experts meet to challenge approaches of testing and developing cancer treatments

Post Your Comments:
(Date:5/19/2013)... New York, NY (PRWEB) May 19, 2013 ... they have filed a diving accident lawsuit on ... of a tragic dive into shallow water. The diving accident ... State New York, Suffolk County, alleges the Defendant held the ... warnings or signs against diving in the area. (Case No. ...
(Date:5/19/2013)... CO (PRWEB) May 19, 2013 Daily Gossip ... guide 17 Cheat Foods That Burn Fat to ... its readers. , The review is a ... followed by the writer's recommendation. , The two nutritionists have ... that is responsible for the caloric intake and expenditure of ...
(Date:5/19/2013)... May 19 (HealthDay News) -- Although spring arrived late ... summer allergy season will still be strong, according to ... Birmingham. Dr. Richard Waguespack, clinical professor in the ... results in a robust summer allergy season. However, some ... sneezing, wheezing and coughing, he added. "Tree pollen ...
(Date:5/19/2013)... Healthcare leaders will gather at the ... Walt Disney World Swan and Dolphin in Orlando, Fla., ... care delivery and healthcare reform and implementation. , “Reform ... markets, with consolidation, efficiency and reduced payments ... Ebert, Amerinet president and CEO. “There is a real ...
(Date:5/19/2013)... 2013 Actos lawsuit claims ... underway in U.S. District Court, Western District of Louisiana. ... 3rd, the Court has modified the litigation’s Bellwether Nomination ... rather than four. The next Status Conference in the ... (In re: Actos Product Liability Litigation, MDL No. 2299) ...
Breaking Medicine News(10 mins):Health News:Alonso Krangle Files Diving Accident Lawsuit on Behalf of Suffolk County Man Rendered Quadraplegic in Tragic Diving Accident at Long Island Beach 2Health News:Alonso Krangle Files Diving Accident Lawsuit on Behalf of Suffolk County Man Rendered Quadraplegic in Tragic Diving Accident at Long Island Beach 3Health News:The "17 Cheat Foods That Burn Fat" Review and Diet Plan Secrets Revealed by Daily Gossip 2Health News:Managing Seasonal Allergies 2Health News:Healthcare Leaders Gather at 2013 Amerinet Member Conference to Share New Ways to Reduce Costs and Enhance Care Delivery 2Health News:Actos Lawyers at Bernstein Liebhard LLP Note Issuance of New Case Management Order in Federal Actos Bladder Cancer Litigation 2Health News:Actos Lawyers at Bernstein Liebhard LLP Note Issuance of New Case Management Order in Federal Actos Bladder Cancer Litigation 3
(Date:5/17/2013)... /PRNewswire-iReach/ -- The escalation of new biological drugs, ... emphasis on alternate delivery technologies. Alternate delivery technologies ... factors are converging to create both risk ... device partners . These include new classes of ... toward self-administration for chronic diseases, shifting patient demographics ...
(Date:5/17/2013)... SEATTLE , May 17, 2013  Atossa Genetics, Inc. ... today that Kyle Guse , Chief Financial ... Marcum LLP MicroCap Conference on Thursday, May 30, 2013, in ... Hyatt Hotel. The Company,s presentation is scheduled ... via a live webcast. To access the webcast, go to ...
(Date:5/16/2013)... SINGAPORE and ZURICH , May ... Agency for Science, Technology and Research (A*STAR) and ... the first healthy volunteer has been dosed in a Phase ... on Cytos, proprietary bacteriophage Qbeta virus-like particle (VLP) technology. In ... of this novel vaccine candidate and its potential to protect ...
Breaking Medicine Technology:Pharmaceutical Makers and Delivery Device Partners Rethink Delivery Technologies - New Report Examines this Evolving Segment 2Pharmaceutical Makers and Delivery Device Partners Rethink Delivery Technologies - New Report Examines this Evolving Segment 3Atossa Genetics to Present at the Second Annual Marcum LLP MicroCap Conference 2Atossa Genetics to Present at the Second Annual Marcum LLP MicroCap Conference 3A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 2A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 3A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 4A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 5A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 6
Cached News: